AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • October 1st, 2019 • Ocugen, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
This AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENT (this “Amendment”), is made and entered into as of September 26, 2019, between Medavate Corp., a Colorado corporation (“Buyer”) and Histogenics Corporation, a Delaware corporation (“Seller”). Capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in that certain Asset Purchase Agreement dated as of May 7, 2019 between Buyer and Seller (the “Asset Purchase Agreement”).
